Aclarion Announces Initial Payer Coverage Of Nociscan By AXA
Portfolio Pulse from Benzinga Newsdesk
Aclarion has announced that AXA will provide initial payer coverage for its Nociscan technology. This development marks a significant milestone for Aclarion as it could lead to increased adoption and revenue growth.
June 26, 2024 | 12:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aclarion has secured initial payer coverage for its Nociscan technology from AXA. This partnership is expected to boost the adoption of Nociscan and potentially increase Aclarion's revenue.
The initial payer coverage by AXA is a significant milestone for Aclarion, as it could lead to increased adoption of Nociscan. This development is likely to positively impact Aclarion's revenue and market position.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100